Salivary neutrophils level as an indicator of bone marrow engraftment
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
20208965
DOI
10.5507/bp.2009.051
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Multiple Myeloma drug therapy therapy MeSH
- Mucositis chemically induced prevention & control MeSH
- Lymphoma, Non-Hodgkin drug therapy therapy MeSH
- Neutrophils * MeSH
- Leukocyte Count MeSH
- Graft Survival * MeSH
- Saliva cytology MeSH
- Dental Care MeSH
- Bone Marrow Transplantation * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
AIM: The aim of this study was to investigate the neutrophils level in saliva as an adequate alternative to other methods for evaluating the neutrophil engraftment after autologous stem cell transplantation (ASCT) in hemato-oncology. METHOD: A total of 35 patients treated for non-Hodgkin's lymphoma or multiple myeloma were stomatologically examined before planned high-dose chemotherapy with ASCT. After removal of potential foci of odontogenic infection all the patients underwent transplantation and during the treatment they were monitored for the level of neutrophils in saliva as a possible early indicator of the neutrophil engraftment. Neutrophil levels in saliva were compared to the neutrophil level in blood and to the degree of oral mucositis (the nurses study). RESULTS: An increase of salivary neutrophils in the mouth rinse of > 25 x 10/\6/l was identified as an early sign of successful neutrophil engraftment that occurred 1 to 2 days before the rise of neutrophils in peripheral blood (> 0.5- x 10/\9/l). CONCLUSIONS: Follow-up of neutrophil levels in saliva might be an adequate alternative to other methods for evaluating the neutrophil engraftment after ASCT in hemato-oncology.
References provided by Crossref.org